← Back to Search
Collecting Blood Samples from Patients with and Without Cancer to Evaluate Tests for Early Cancer Detection
Brunswick, ME
N/A
Recruiting
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights
No Placebo-Only Group
Summary
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
See full description
Eligible Conditions
- Uterine Cancer
- Cancer
- Esophageal cancer
- Chronic Lymphocytic Leukemia
- Kidney Cancer
- Breast Cancer
- Ovarian Cancer
- Gastric cancer
- Bladder Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Breast cancer
- Lung Cancer
- Sarcoma
- Liver and Bile Duct Tumors
- Lymphoma
- Leukemia
- Gastroesophageal Junction Adenocarcinoma
- Blood Cancers
- Melanoma
- Multiple Myeloma
- Stomach Cancer
- Gastric Cancer
- Acute Lymphoblastic Leukemia
- Thyroid Cancer
- Prostate Cancer
- Esophageal Cancer
- Head and Neck Cancers
- Acute Myeloid Leukemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Provision of blinded reference set of cancer versus non-cancer blood samples
Secondary study objectives
Test performance at the time of initial cancer diagnosis by clinical stage
Test performance at the time of initial cancer diagnosis by tumor type
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Screening (questionnaire, biospecimen collection)Experimental Treatment2 Interventions
Participants complete a questionnaire at baseline. Participants undergo collection of blood samples at registration and at 12 months after registration. Patients with a cancer diagnosis may undergo collection of tissue samples at registration and 12 months after registration.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~1810
Find a Location
Closest Location:Mid Coast Hospital· Brunswick, ME
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
14,039 Previous Clinical Trials
41,144,675 Total Patients Enrolled
Alliance for Clinical Trials in OncologyLead Sponsor
519 Previous Clinical Trials
220,284 Total Patients Enrolled
Marie Wood, MDStudy ChairUniversity of Colorado, Denver
2 Previous Clinical Trials
48 Total Patients Enrolled